Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 333

1.

Early revascularization and long-term mortality in high-risk patients with non-ST-elevation myocardial infarction. The CARDIOCHUS-HUSJ registry.

Álvarez Álvarez B, Abou Jokh Casas C, Cordero A, Martínez Gómez Á, Cid Álvarez AB, Agra Bermejo R, García Acuña JM, Gude Sampedro F, González Juanatey JR.

Rev Esp Cardiol (Engl Ed). 2019 May 20. pii: S1885-5857(19)30078-7. doi: 10.1016/j.rec.2019.02.015. [Epub ahead of print] English, Spanish.

PMID:
31122784
2.

Initial real-world experience with PCSK-9 inhibitors in current indications for reimbursement in Spain.

Cordero A, Fácila L, Rodríguez-Mañero M, Gómez-Martínez MJ, Bertomeu-Martínez V, González-Juanatey JR.

Rev Esp Cardiol (Engl Ed). 2019 May 15. pii: S1885-5857(19)30103-3. doi: 10.1016/j.rec.2019.03.008. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31103377
3.

The Two-way Relationship Between Cancer and Atherosclerosis.

Raposeiras Roubín S, Cordero A.

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):487-494. doi: 10.1016/j.rec.2018.12.010. Epub 2019 May 1. Review. English, Spanish.

PMID:
31053376
4.

Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors.

Cordero A, Fácila L, Galve E, González Juanatey JR.

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):518-519. doi: 10.1016/j.rec.2018.11.018. Epub 2019 Apr 10. English, Spanish. No abstract available.

PMID:
30981589
5.

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma.

Miska J, Lee-Chang C, Rashidi A, Muroski ME, Chang AL, Lopez-Rosas A, Zhang P, Panek WK, Cordero A, Han Y, Ahmed AU, Chandel NS, Lesniak MS.

Cell Rep. 2019 Apr 2;27(1):226-237.e4. doi: 10.1016/j.celrep.2019.03.029.

6.

A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population.

Rodríguez-Mañero M, López-Pardo E, Cordero A, Ruano-Ravina A, Novo-Platas J, Pereira-Vázquez M, Martínez-Gómez Á, García-Seara J, Martínez-Sande JL, Peña-Gil C, Mazón P, García-Acuña JM, Valdés-Cuadrado L, González-Juanatey JR.

Int J Chron Obstruct Pulmon Dis. 2019 Feb 12;14:371-380. doi: 10.2147/COPD.S174443. eCollection 2019.

7.

Causes of Higher In-hospital Mortality Due to ACS in the Canary Islands and Possible Solutions.

Cordero A, Bertomeu Martínez V.

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):443-444. doi: 10.1016/j.rec.2018.11.019. Epub 2019 Mar 9. English, Spanish. No abstract available.

PMID:
30862428
8.

Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma.

Mohanty S, Yerneni K, Theruvath JL, Graef CM, Nejadnik H, Lenkov O, Pisani L, Rosenberg J, Mitra S, Cordero AS, Cheshier S, Daldrup-Link HE.

Cell Death Dis. 2019 Jan 15;10(2):36. doi: 10.1038/s41419-018-1285-3.

9.

Diabetes mellitus, frailty and prognosis in very elderly patients with acute coronary syndromes.

Gual M, Formiga F, Ariza-Solé A, López-Palop R, Sanchís J, Marín F, Vidán MT, Martínez-Sellés M, Sionis A, Sánchez-Salado JC, Lorente V, Díez-Villanueva P, Vives-Borrás M, Cordero A, Bueno H, Alegre O, Abu-Assi E, Cequier À; LONGEVO-SCA registry investigators.

Aging Clin Exp Res. 2019 Jan 22. doi: 10.1007/s40520-018-01118-x. [Epub ahead of print]

PMID:
30671867
10.

Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model.

Panek WK, Pituch KC, Miska J, Kim JW, Rashidi A, Kanojia D, Lopez-Rosas A, Han Y, Yu D, Chang CL, Kane JR, Zhang P, Cordero A, Lesniak MS.

Mol Neurobiol. 2018 Nov 20. doi: 10.1007/s12035-018-1430-0. [Epub ahead of print]

PMID:
30460615
11.

Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, Aguilar H, Gómez-Baldó L, Petit A, Vidal A, Climent F, Hernández-Losa J, Cordero Á, González-Suárez E, Sánchez-Mut JV, Esteller M, Llatjós R, Varela M, López JI, García N, Extremera AI, Gumà A, Ortega R, Plà MJ, Fernández A, Pernas S, Falo C, Morilla I, Campos M, Gil M, Román A, Molina-Molina M, Ussetti P, Laporta R, Valenzuela C, Ancochea J, Xaubet A, Casanova Á, Pujana MA.

PLoS One. 2018 Nov 12;13(11):e0207586. doi: 10.1371/journal.pone.0207586. eCollection 2018.

12.

Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome.

Cordero A, Rodriguez-Mañero M, García-Acuña JM, Bertomeu-González V, Agra-Bermejo R, Cid B, Alvarez B, Bertomeu-Martínez V, González-Juanatey JR.

Int J Cardiol. 2019 Feb 1;276:20-25. doi: 10.1016/j.ijcard.2018.10.082. Epub 2018 Nov 1.

PMID:
30414748
13.

Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.

Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, de la Torre MP, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group.

PLoS One. 2018 Sep 27;13(9):e0205047. doi: 10.1371/journal.pone.0205047. eCollection 2018.

14.

Global folate status in women of reproductive age: a systematic review with emphasis on methodological issues.

Rogers LM, Cordero AM, Pfeiffer CM, Hausman DB, Tsang BL, De-Regil LM, Rosenthal J, Razzaghi H, Wong EC, Weakland AP, Bailey LB.

Ann N Y Acad Sci. 2018 Nov;1431(1):35-57. doi: 10.1111/nyas.13963. Epub 2018 Sep 21.

15.

Clinical impact of mineralocorticoid receptor antagonists treatment after acute coronary syndrome in the real world: A propensity score matching analysis.

Agra-Bermejo R, Cordero A, Rodríguez-Mañero M, García Acuña JM, Álvarez Álvarez B, Martínez Á, Álvarez Rodríguez L, Abou-Jokh C, Cid Álvarez B, González-Juanatey JR.

Eur Heart J Acute Cardiovasc Care. 2018 Aug 17:2048872618795422. doi: 10.1177/2048872618795422. [Epub ahead of print]

PMID:
30117745
16.

Cancer and Acute Coronary Syndrome. A Close, but Complicated Relationship. Response.

Cordero A, Bertomeu-González V, Núñez J, Bertomeu-Martínez V.

Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):880-881. doi: 10.1016/j.rec.2018.05.033. Epub 2018 Aug 7. English, Spanish. No abstract available.

PMID:
30097394
17.

Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication.

Cordero A, García-Acuña JM, Rodríguez-Mañero M, Agra-Bermejo R, Cid B, Alvarez B, Bertomeu-González V, Fácila L, Bertomeu-Martínez V, González-Juanatey JR.

Int J Cardiol. 2018 Nov 1;270:36-41. doi: 10.1016/j.ijcard.2018.06.057. Epub 2018 Jun 14.

PMID:
29945806
18.

Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".

Cordero A, Bertomeu-González V, Rodriguez-Mañero M.

Circulation. 2018 Jun 12;137(24):2658-2659. doi: 10.1161/CIRCULATIONAHA.118.033559. No abstract available.

PMID:
29891623
19.

Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials.

Lozano I, Lopez-Palop R, Garcia Rubio J, Cordero A.

J Am Coll Cardiol. 2018 Jun 12;71(23):2710. doi: 10.1016/j.jacc.2018.02.081. No abstract available.

PMID:
29880137
20.

Prognosis and lipid profile improvement by a specialized outpatient clinic for acute coronary syndrome patients.

Cordero A, Bertomeu-González V, Moreno-Arribas J, Castillo J, Quiles J, Bertomeu-Martinez V.

Atherosclerosis. 2018 Aug;275:28-34. doi: 10.1016/j.atherosclerosis.2018.05.026. Epub 2018 May 21.

PMID:
29852402

Supplemental Content

Loading ...
Support Center